SK280516B6 - Amidy, spôsob ich prípravy a farmaceutická kompozí - Google Patents
Amidy, spôsob ich prípravy a farmaceutická kompozí Download PDFInfo
- Publication number
- SK280516B6 SK280516B6 SK2342-92A SK234292A SK280516B6 SK 280516 B6 SK280516 B6 SK 280516B6 SK 234292 A SK234292 A SK 234292A SK 280516 B6 SK280516 B6 SK 280516B6
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- phenyl
- hydroxy
- mmol
- aromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919116069A GB9116069D0 (en) | 1991-07-25 | 1991-07-25 | Therapeutic amides |
GB929209416A GB9209416D0 (en) | 1992-04-30 | 1992-04-30 | Therapeutic amides |
Publications (2)
Publication Number | Publication Date |
---|---|
SK234292A3 SK234292A3 (en) | 1995-03-08 |
SK280516B6 true SK280516B6 (sk) | 2000-03-13 |
Family
ID=26299285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK2342-92A SK280516B6 (sk) | 1991-07-25 | 1992-07-24 | Amidy, spôsob ich prípravy a farmaceutická kompozí |
Country Status (25)
Country | Link |
---|---|
US (7) | US5272163A (zh) |
EP (1) | EP0524781B1 (zh) |
JP (1) | JP3192228B2 (zh) |
KR (1) | KR100239077B1 (zh) |
CN (1) | CN1038413C (zh) |
AT (1) | ATE136027T1 (zh) |
AU (1) | AU648423B2 (zh) |
CA (1) | CA2074605A1 (zh) |
CZ (1) | CZ282503B6 (zh) |
DE (1) | DE69209395T2 (zh) |
DK (1) | DK0524781T3 (zh) |
ES (1) | ES2084944T3 (zh) |
FI (1) | FI112940B (zh) |
GB (1) | GB9214120D0 (zh) |
GR (1) | GR3019446T3 (zh) |
HK (1) | HK1003570A1 (zh) |
HU (2) | HU213605B (zh) |
IE (1) | IE72507B1 (zh) |
IL (1) | IL102626A (zh) |
NO (1) | NO178300C (zh) |
NZ (1) | NZ243686A (zh) |
PL (1) | PL171933B1 (zh) |
SG (1) | SG48002A1 (zh) |
SK (1) | SK280516B6 (zh) |
TW (1) | TW221053B (zh) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5340819A (en) * | 1991-10-21 | 1994-08-23 | Imperial Chemical Industries Plc | Method for treating urinary incontinence using 9-(3-nitrophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H) acridinedione |
IL105558A (en) * | 1992-05-18 | 1998-04-05 | Zeneca Ltd | Tertiary carbinols with channel activity potassium process for their preparation and pharmaceutical preparations containing them |
GB9305295D0 (en) * | 1993-03-15 | 1993-05-05 | Zeneca Ltd | Therapeutic compounds |
GB9310095D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Therapeutic compounds |
GB9310069D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Heterocyclic compounds |
AT402926B (de) * | 1994-12-05 | 1997-09-25 | Hafslund Nycomed Pharma | Heterocyclische amide, verfahren zu ihrer herstellung und verwendung |
DE19506652A1 (de) * | 1995-02-25 | 1996-08-29 | Nycomed Arzneimittel Gmbh | Heterocyclische Amide, Verfahren zu ihrer Herstellung und ihre Verwendung |
ES2214532T3 (es) | 1995-03-03 | 2004-09-16 | Endo Pharmaceuticals Inc. | Uso de dextrorfano o dextrometorfano para el tratamiento de la incontinencia urinaria. |
DE69612835T2 (de) * | 1995-10-16 | 2001-10-04 | Kyowa Hakko Kogyo Kk | Tricyclische verbindungen |
US5756005A (en) * | 1995-11-01 | 1998-05-26 | Rohm And Haas Company | Stabilization of non-halogenated 3-isothiazolones in aggressive systems |
FR2747039B1 (fr) * | 1996-04-05 | 1998-05-22 | Oreal | Utilisation du n-(3,4-dicyano-phenyl)- 3,3,3-trifluoro- 2-hydroxy-2-methylpropionamide pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
JP2000508296A (ja) * | 1996-03-06 | 2000-07-04 | ロレアル | 髪の成長の刺激または誘発および/または抜毛防止のためのn―アリール―2―ヒドロキシアルキルアミドの使用 |
GB9607458D0 (en) * | 1996-04-10 | 1996-06-12 | Zeneca Ltd | Enzymatic process for stereoselective preparation of therapeutic amides |
DE19614856A1 (de) * | 1996-04-16 | 1997-10-23 | Basf Ag | Herbizide heterocyclisch anellierte Benzoylisothiazole |
DE19614858A1 (de) * | 1996-04-16 | 1997-10-23 | Basf Ag | Herbizide heterocyclisch substituierte Benzoylisothiazole |
DE19614859A1 (de) * | 1996-04-16 | 1997-10-23 | Basf Ag | Herbizide Benzoylisothiazole |
US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
ATE397088T1 (de) * | 1996-07-10 | 2008-06-15 | Lonza Ag | Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e |
JP2001500864A (ja) * | 1996-09-13 | 2001-01-23 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害物質 |
AU738757B2 (en) * | 1997-04-15 | 2001-09-27 | Kyowa Hakko Kirin Co., Ltd. | Tricyclic compounds |
AU8684598A (en) * | 1997-08-05 | 1999-03-01 | American Home Products Corporation | Anthranilic acid analogs |
US6127392A (en) * | 1997-08-05 | 2000-10-03 | American Home Products Corporation | Anthranilic acid analogs |
CA2297409A1 (en) * | 1997-08-05 | 1999-02-18 | American Home Products Corporation | Anthranilic acid analogs |
FR2770842B1 (fr) * | 1997-11-13 | 1999-12-17 | Oreal | Nouveaux composes derives de n-aryl 2-hydroxy alkylamides |
DK0930302T3 (da) * | 1998-01-16 | 2003-07-21 | Hoffmann La Roche | Benzosulfonderivater |
GB9804648D0 (en) | 1998-03-06 | 1998-04-29 | Zeneca Ltd | Chemical compounds |
US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
GB9805520D0 (en) | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
GB9811427D0 (en) | 1998-05-29 | 1998-07-22 | Zeneca Ltd | Chemical compounds |
US6096770A (en) * | 1998-08-03 | 2000-08-01 | American Home Products Corporation | Anthranilic acid analogs |
PT1155138E (pt) | 1999-02-23 | 2005-04-29 | Lonza Ag | Processo para a producao de derivados de acido 3,3,3-trifluorometil-2-alquilpropionico opticamente activos |
EP1394150B1 (en) | 1999-02-24 | 2011-01-19 | F. Hoffmann-La Roche AG | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
US6790978B2 (en) | 1999-03-29 | 2004-09-14 | Novartis Ag | Thyromimetic organic compounds |
US6599942B1 (en) | 1999-03-29 | 2003-07-29 | Novartis Ag | Thyromimetic organic compounds |
US7030109B2 (en) | 1999-07-19 | 2006-04-18 | Pharmacia & Upjohn Company | 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
MY122278A (en) * | 1999-07-19 | 2006-04-29 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
AU6715200A (en) | 1999-09-04 | 2001-04-10 | Astrazeneca Ab | Amides as inhibitors for pyruvate dehydrogenase |
JP2003508514A (ja) | 1999-09-04 | 2003-03-04 | アストラゼネカ アクチボラグ | 化学的化合物 |
BR0013694A (pt) | 1999-09-04 | 2002-05-21 | Astrazeneca Ab | Composto, processo para a preparação de um composto, composição farmacêutica, e, uso de um composto |
DE10061876A1 (de) * | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
US7765153B2 (en) * | 2003-06-10 | 2010-07-27 | Kagi, Inc. | Method and apparatus for verifying financial account information |
TWI280239B (en) | 2003-07-15 | 2007-05-01 | Hoffmann La Roche | Process for preparation of pyridine derivatives |
US7404324B2 (en) * | 2005-08-19 | 2008-07-29 | Honeywell International Inc. | Gunhard shock isolation system |
KR20080043852A (ko) | 2005-09-23 | 2008-05-19 | 에프. 호프만-라 로슈 아게 | 신규 투여 제형 |
US10865184B2 (en) | 2015-04-21 | 2020-12-15 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10654809B2 (en) | 2016-06-10 | 2020-05-19 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10806720B2 (en) | 2015-04-21 | 2020-10-20 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10093613B2 (en) | 2015-04-21 | 2018-10-09 | Gtx, Inc. | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
CN105218418A (zh) * | 2015-10-01 | 2016-01-06 | 宜春学院 | 一种硫醚的制备方法 |
US11230523B2 (en) | 2016-06-10 | 2022-01-25 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
CN112007027B (zh) * | 2020-09-14 | 2022-07-15 | 长春金赛药业有限责任公司 | 含酯基芳香丙酰胺类化合物及其代谢产物在制备治疗心衰药物中的应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468878A (en) * | 1963-05-29 | 1969-09-23 | American Home Prod | Process for preparing 3 - acyloxy-1,3-dihydro - 5 - aryl-2h-1,4-benzodiazepin-2-ones |
US3365485A (en) * | 1963-05-29 | 1968-01-23 | American Home Prod | 2-acetoxyacetamido-5-chlorobenzophenone |
NL7008629A (zh) * | 1969-06-25 | 1970-12-29 | ||
NL7008627A (zh) * | 1969-06-25 | 1970-12-29 | ||
US3715375A (en) * | 1970-09-17 | 1973-02-06 | Merck & Co Inc | New diphenyl sulfones |
DE2730174C2 (de) * | 1977-07-04 | 1981-12-10 | Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren | Aminobenzoesäurederivate und Arzneimittel enthaltend solche Aminobenzoesäurederivate |
EP0002309B1 (en) * | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
US4191775A (en) * | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
JPS55108796A (en) * | 1979-02-14 | 1980-08-21 | Matsushita Electric Ind Co Ltd | Device for inserting component |
NZ197008A (en) * | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
AU8961382A (en) * | 1981-11-06 | 1983-05-12 | Imperial Chemical Industries Plc | Amide derivatives |
DE3372965D1 (en) * | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
GB8406000D0 (en) * | 1984-03-07 | 1984-04-11 | Ici Plc | Olefine derivatives |
NO174506B (no) * | 1984-10-30 | 1994-02-07 | Usv Pharma Corp | Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser |
AU5259486A (en) * | 1985-01-17 | 1986-07-24 | Usv Pharmaceutical Corp. | Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments |
GB8617652D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
GB8617653D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US5272982A (en) * | 1989-06-01 | 1993-12-28 | Giat Industries | Device for maintaining a projectile relative to the casing of a telescoping ammunition |
IE902111A1 (en) * | 1989-07-18 | 1991-06-19 | Ici Plc | Diaryl ether cycloalkanes |
IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
-
1992
- 1992-07-03 GB GB929214120A patent/GB9214120D0/en active Pending
- 1992-07-17 EP EP92306588A patent/EP0524781B1/en not_active Expired - Lifetime
- 1992-07-17 ES ES92306588T patent/ES2084944T3/es not_active Expired - Lifetime
- 1992-07-17 SG SG1996006045A patent/SG48002A1/en unknown
- 1992-07-17 DK DK92306588.2T patent/DK0524781T3/da active
- 1992-07-17 AT AT92306588T patent/ATE136027T1/de not_active IP Right Cessation
- 1992-07-17 DE DE69209395T patent/DE69209395T2/de not_active Expired - Fee Related
- 1992-07-23 US US07/918,982 patent/US5272163A/en not_active Expired - Lifetime
- 1992-07-23 NZ NZ243686A patent/NZ243686A/en unknown
- 1992-07-23 IL IL10262692A patent/IL102626A/en not_active IP Right Cessation
- 1992-07-23 AU AU20476/92A patent/AU648423B2/en not_active Ceased
- 1992-07-24 PL PL92295405A patent/PL171933B1/pl unknown
- 1992-07-24 HU HU9202429A patent/HU213605B/hu not_active IP Right Cessation
- 1992-07-24 IE IE922427A patent/IE72507B1/en not_active IP Right Cessation
- 1992-07-24 FI FI923379A patent/FI112940B/fi active
- 1992-07-24 CA CA002074605A patent/CA2074605A1/en not_active Abandoned
- 1992-07-24 SK SK2342-92A patent/SK280516B6/sk unknown
- 1992-07-24 NO NO922942A patent/NO178300C/no unknown
- 1992-07-24 CZ CS922342A patent/CZ282503B6/cs not_active IP Right Cessation
- 1992-07-25 KR KR1019920013404A patent/KR100239077B1/ko not_active IP Right Cessation
- 1992-07-25 CN CN92109759A patent/CN1038413C/zh not_active Expired - Fee Related
- 1992-07-27 JP JP19995492A patent/JP3192228B2/ja not_active Expired - Fee Related
- 1992-08-08 TW TW081106280A patent/TW221053B/zh active
-
1993
- 1993-09-24 US US08/126,350 patent/US5382598A/en not_active Expired - Lifetime
-
1994
- 1994-10-26 US US08/329,188 patent/US5474999A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/476,007 patent/US5565477A/en not_active Expired - Lifetime
- 1995-06-07 US US08/476,413 patent/US5565465A/en not_active Expired - Lifetime
- 1995-06-07 US US08/476,407 patent/US5567735A/en not_active Expired - Lifetime
- 1995-06-16 HU HU95P/P00228P patent/HU211138A9/hu unknown
-
1996
- 1996-03-28 GR GR960400647T patent/GR3019446T3/el unknown
- 1996-08-23 US US08/701,820 patent/US5684198A/en not_active Expired - Lifetime
-
1998
- 1998-03-26 HK HK98102594A patent/HK1003570A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK280516B6 (sk) | Amidy, spôsob ich prípravy a farmaceutická kompozí | |
JP5632612B2 (ja) | ラクタム化合物又はその塩及びppar活性化剤 | |
TWI409247B (zh) | 4-取代之苯氧基苯基乙酸衍生物 | |
EP0617010B1 (en) | Therapeutic compounds | |
JP2009501721A (ja) | レチノイン酸受容体における活性を伴う化合物 | |
JP2002506859A (ja) | ベンゼンスルホンアミド誘導体およびそれらの薬剤としての使用 | |
EP0979823B1 (en) | Novel amide compounds and drugs containing the same | |
EP0539154A1 (en) | Acridine-1,8-dione-derivatives as therapeutic agents | |
DK2875026T3 (en) | IMIDAZOPYRIDINE DERIVATE USED TO TREAT DIABETES | |
JPH06263735A (ja) | ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲a2▼阻害剤 | |
JP4191269B2 (ja) | 新規なアニリド化合物及びこれを含有する医薬 | |
CA2663943A1 (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders | |
EP3330263B1 (en) | Phenylurea derivatives as isocitrate dehydrogenase 2 inhibitors for treating cancer | |
JP2003505367A (ja) | マトリックスメタロプロテイナーゼ阻害剤としての3−アリールスルホニル−2−(置換メチル)プロパン酸誘導体 | |
RU2074173C1 (ru) | Амиды, способы их получения и фармацевтическая композиция, обладающая свойствами открывателя каналов для клеточного калия | |
JP3734870B2 (ja) | ピリミジン誘導体及びこれを含有する医薬 | |
EP4257583A1 (en) | Biphenyl pyrrolidine and biphenyl dihydroimidazole derivatives for inhibiting activity of 5-ht7 serotonin receptor, and pharmaceutical composition comprising same as active ingredient | |
JP2001507001A (ja) | アルドースレダクターゼ阻害剤としてのニトロメチルチオベンゼン誘導体 |